Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BTK inhibitor 10 is a potent and orally active BTK inhibitor. It has the potential for rheumatoid arthritis treatment.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | BTK inhibitor 10 is a potent and orally active BTK inhibitor. It has the potential for rheumatoid arthritis treatment. |
Targets&IC50 | BTK: |
In vivo | In CIA mice, BTK inhibitor 10 (oral gavage; 30 mg/kg; 21 days; once daily) has a significant improvement in arthritis symptoms. The damage of each of the 4 paws in mice is divided into 0-4 to calculate the total score of the limbs. BTK030 (21 days; p.o.) reduces the arthritic score to 3.62 while the control group shows a value of 8.33. |
Molecular Weight | 441.48 |
Formula | C25H23N5O3 |
CAS No. | 2241732-30-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BTK inhibitor 10 2241732-30-7 Others inhibitor inhibit